Table: Towa Pharmaceutical -2019/20 parent results

TOWA PHARMACEUTICAL

14/05/2020 07:00

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            107.65          102.43                                
                 (+5.1 pct)      (+12.6 pct)                             
  Operating         16.74           15.80                                
                 (+5.9 pct)      (+30.5 pct)                             
  Recurring         21.70           18.97                                
                 (+14.4 pct)    (+115.0 pct)                             
  Net               15.25           13.61                                
                 (+12.1 pct)    (+148.4 pct)                             
  EPS            309.99 yen      276.62 yen                              
  EPS Diluted    286.73 yen      255.88 yen                              
  Ann Div         44.00 yen      107.50 yen      44.00 yen               
  -Q2 Div         22.00 yen       47.50 yen      22.00 yen               
  -Q4 Div         22.00 yen       60.00 yen      22.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T